Compounds > 1-(3-chlorophenyl)piperazine
Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Atrophy

1-(3-chlorophenyl)piperazine has been researched along with Atrophy in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
New, AS1
Hazlett, EA1
Buchsbaum, MS1
Goodman, M1
Mitelman, SA1
Newmark, R1
Trisdorfer, R1
Haznedar, MM1
Koenigsberg, HW1
Flory, J1
Siever, LJ1

Other Studies

1 other study available for 1-(3-chlorophenyl)piperazine and Atrophy

ArticleYear
Amygdala-prefrontal disconnection in borderline personality disorder.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:7

    Topics: Adult; Aggression; Amygdala; Atrophy; Borderline Personality Disorder; Emotions; Energy Metabolism;

2007